Literature DB >> 15050726

Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts.

Marie Csete1, Luis Rodriguez, Melissa Wilcox, Seetharam Chadalavada.   

Abstract

Exogenous erythropoietin (EPO) is a potent neurotrophic factor in vivo, protective against neuronal death in animal models of brain ischemia and human stroke. To date, reports on the distribution of EPO receptor in brain suggest that it is expressed mostly on capillaries. This receptor pattern suggests an indirect effect of EPO on neurons. In these studies, we show that EPO receptor is abundantly expressed on adult dopaminergic neurons, suggesting a direct effect of EPO on neurons. Furthermore, we show that EPO mediates the classic neurotrophic effects of proliferation, differentiation and maintenance in a dopaminergic cell line. The biology of therapeutically administered EPO in brain is a function of its receptor distribution, and the neuronal expression of EPO receptor on adult CNS neurons is consistent with EPO's potent neurotrophic function in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050726     DOI: 10.1016/j.neulet.2004.01.068

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.

Authors:  Claudia Bartels; Kira Späte; Henning Krampe; Hannelore Ehrenreich
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

Review 2.  How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson's disease?

Authors:  Jia Liu; Hong-Yun Huang
Journal:  Neurosci Bull       Date:  2007-11       Impact factor: 5.203

3.  Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia.

Authors:  Wei Liu; Yan Shen; Jennifer M Plane; David E Pleasure; Wenbin Deng
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

4.  Erythropoietin accelerates functional recovery after peripheral nerve injury.

Authors:  John C Elfar; Justin A Jacobson; J Edward Puzas; Randy N Rosier; Michael J Zuscik
Journal:  J Bone Joint Surg Am       Date:  2008-08       Impact factor: 5.284

Review 5.  Vascular growth factors in neuropsychiatry.

Authors:  Samuel S Newton; Neil M Fournier; Ronald S Duman
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

6.  Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-alpha): relevance in neural progenitor/stem cells.

Authors:  Javorina Milosevic; Irena Adler; Anatol Manaenko; Sigrid C Schwarz; Gail Walkinshaw; Michael Arend; Lee A Flippin; Alexander Storch; Johannes Schwarz
Journal:  Neurotox Res       Date:  2009-03-20       Impact factor: 3.911

7.  Protective effect of erythropoietin against 1-methyl-4-phenylpyridinium-induced neurodegenaration in PC12 cells.

Authors:  Yan Wu; You Shang; Sheng-Gang Sun; Ren-Gang Liu; Wen-Qiong Yang
Journal:  Neurosci Bull       Date:  2007-05       Impact factor: 5.203

Review 8.  Neuroplasticity and the next wave of antidepressant strategies.

Authors:  Shawn Hayley; Darcy Litteljohn
Journal:  Front Cell Neurosci       Date:  2013-11-20       Impact factor: 5.505

9.  Erythropoietin improves neurobehavior by reducing dopaminergic neuron loss in a 6‑hydroxydopamine‑induced rat model.

Authors:  Chen Qi; Mingxin Xu; Jing Gan; Xinxin Yang; Na Wu; Lu Song; Weien Yuan; Zhenguo Liu
Journal:  Int J Mol Med       Date:  2014-06-17       Impact factor: 4.101

10.  Erythropoietin enhanced recovery after peripheral nerve injury.

Authors:  Max Modrak; Leigh Sundem; John Elfar
Journal:  Neural Regen Res       Date:  2017-08       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.